241 related articles for article (PubMed ID: 32861945)
1. Measles virus in cancer therapy.
Mühlebach MD
Curr Opin Virol; 2020 Apr; 41():85-97. PubMed ID: 32861945
[TBL] [Abstract][Full Text] [Related]
2. [The Advances of Oncolytic Herpes Simplex Virus in Cancer Therapy].
Hao M; Huang C; Xia N
Bing Du Xue Bao; 2016 Jul; 32(4):516-22. PubMed ID: 29996042
[TBL] [Abstract][Full Text] [Related]
3. Generation of recombinant measles virus containing the wild-type P gene to improve its oncolytic efficiency.
Alizadeh R; Ghanei M; Arashkia A; Dorostkar R; Azadmanesh K
Microb Pathog; 2019 Oct; 135():103631. PubMed ID: 31381964
[No Abstract] [Full Text] [Related]
4. Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles Virus.
Allagui F; Achard C; Panterne C; Combredet C; Labarrière N; Dréno B; Elgaaied AB; Pouliquen D; Tangy F; Fonteneau JF; Grégoire M; Boisgerault N
Curr Gene Ther; 2017; 16(6):419-428. PubMed ID: 28042780
[TBL] [Abstract][Full Text] [Related]
5. Potential and clinical translation of oncolytic measles viruses.
Robinson S; Galanis E
Expert Opin Biol Ther; 2017 Mar; 17(3):353-363. PubMed ID: 28129716
[TBL] [Abstract][Full Text] [Related]
6. MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.
Muñoz-Alía MÁ; Nace RA; Tischer A; Zhang L; Bah ES; Auton M; Russell SJ
PLoS Pathog; 2021 Feb; 17(2):e1009283. PubMed ID: 33534834
[TBL] [Abstract][Full Text] [Related]
7. Talimogene laherparepvec (T-VEC) as cancer immunotherapy.
Kohlhapp FJ; Zloza A; Kaufman HL
Drugs Today (Barc); 2015 Sep; 51(9):549-58. PubMed ID: 26488034
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic Virotherapy: A Contest between Apples and Oranges.
Russell SJ; Peng KW
Mol Ther; 2017 May; 25(5):1107-1116. PubMed ID: 28392162
[TBL] [Abstract][Full Text] [Related]
9. Measles to the Rescue: A Review of Oncolytic Measles Virus.
Aref S; Bailey K; Fielding A
Viruses; 2016 Oct; 8(10):. PubMed ID: 27782084
[TBL] [Abstract][Full Text] [Related]
10. Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus.
Scheubeck G; Berchtold S; Smirnow I; Schenk A; Beil J; Lauer UM
Viruses; 2019 Jul; 11(7):. PubMed ID: 31284426
[TBL] [Abstract][Full Text] [Related]
11. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.
Hasegawa K; Pham L; O'Connor MK; Federspiel MJ; Russell SJ; Peng KW
Clin Cancer Res; 2006 Mar; 12(6):1868-75. PubMed ID: 16551872
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic Virotherapy by HSV.
Watanabe D; Goshima F
Adv Exp Med Biol; 2018; 1045():63-84. PubMed ID: 29896663
[TBL] [Abstract][Full Text] [Related]
13. Opportunities to debottleneck the downstream processing of the oncolytic measles virus.
Loewe D; Dieken H; Grein TA; Weidner T; Salzig D; Czermak P
Crit Rev Biotechnol; 2020 Mar; 40(2):247-264. PubMed ID: 31918573
[TBL] [Abstract][Full Text] [Related]
14. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
[TBL] [Abstract][Full Text] [Related]
15. Talimogene Laherparepvec: An Oncolytic Virus Therapy for Melanoma.
Corrigan PA; Beaulieu C; Patel RB; Lowe DK
Ann Pharmacother; 2017 Aug; 51(8):675-681. PubMed ID: 28351167
[TBL] [Abstract][Full Text] [Related]
16. Robust envelope exchange platform for oncolytic measles virus.
Neault S; Bossow S; Achard C; Bell JC; Diallo JS; Leber MF; Ungerechts G
J Virol Methods; 2022 Apr; 302():114487. PubMed ID: 35104497
[TBL] [Abstract][Full Text] [Related]
17. A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells.
Fujiyuki T; Yoneda M; Amagai Y; Obayashi K; Ikeda F; Shoji K; Murakami Y; Sato H; Kai C
Oncotarget; 2015 Sep; 6(28):24895-903. PubMed ID: 26317644
[TBL] [Abstract][Full Text] [Related]
18. A novel armed oncolytic measles vaccine virus for the treatment of cholangiocarcinoma.
Lange S; Lampe J; Bossow S; Zimmermann M; Neubert W; Bitzer M; Lauer UM
Hum Gene Ther; 2013 May; 24(5):554-64. PubMed ID: 23550539
[TBL] [Abstract][Full Text] [Related]
19. Talimogene Laherparepvec: A Review in Unresectable Metastatic Melanoma.
Garnock-Jones KP
BioDrugs; 2016 Oct; 30(5):461-468. PubMed ID: 27516203
[TBL] [Abstract][Full Text] [Related]
20. Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy.
Kohlhapp FJ; Kaufman HL
Clin Cancer Res; 2016 Mar; 22(5):1048-54. PubMed ID: 26719429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]